MedPath

Project Resurgence Communication Trial

Not Applicable
Completed
Conditions
Communication Research
Registration Number
NCT04418947
Lead Sponsor
University of Pennsylvania
Brief Summary

Randomized, double-blind, of standard of care vs additional communication and factorial design of intervention letter vs. control letter and EHR vs mail delivery mechanism in patients who canceled visits and did not reschedule over a 90 day period starting March 9, 2020.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11120
Inclusion Criteria
  • Patients with a cancellation or failure to show for a procedure or visit from March 9, 2020 through June 7, 2020 (90 days) and who have not rescheduled as of the date of randomization
Exclusion Criteria
  • Death

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Percent of Participants With Visit or Procedure With Provider1 month
Secondary Outcome Measures
NameTimeMethod
Percent of Participants With Completed Telemedicine Visit With Provider1 month
Percent of Participants With Scheduled Visit or Procedure With Provider1 month

Trial Locations

Locations (1)

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.